GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 791 filers reported holding GLAXOSMITHKLINE PLC in Q1 2017. The put-call ratio across all filers is 0.93 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $19,000 | -24.0% | 495 | -24.3% | 0.00% | 0.0% |
| Q1 2018 | $25,000 | +47.1% | 654 | +32.1% | 0.00% | 0.0% |
| Q4 2017 | $17,000 | -99.4% | 495 | -99.3% | 0.00% | -99.4% |
| Q3 2017 | $2,914,000 | +7.6% | 71,794 | +14.3% | 0.32% | +2.9% |
| Q2 2017 | $2,707,000 | +5.1% | 62,792 | +2.7% | 0.31% | -2.2% |
| Q1 2017 | $2,576,000 | +15.8% | 61,133 | +5.8% | 0.32% | +10.1% |
| Q4 2016 | $2,224,000 | – | 57,777 | – | 0.29% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |